The most convincing biomarkers in the blood for AD are currently β-amyloid (Aβ) and tau protein because amyloid plaques and neurofibrillary tangles are pathological hallmarks in the brains of patients with AD [1]. This evidence concerns the gene MAPT and Alzheimer disease.